UK Centre for Tobacco and Alcohol Studies, School of Medicine, Clinical Sciences Building, Nottingham City Hospital, University of Nottingham, Nottingham, United Kingdom.
UK Centre for Tobacco and Alcohol Studies, Institute of Psychiatry, Psychology & Neuroscience (IoPPN), King's College London, London, United Kingdom.
PLoS One. 2019 Jul 25;14(7):e0220168. doi: 10.1371/journal.pone.0220168. eCollection 2019.
To estimate tobacco use prevalence in healthcare workers (HCW) by country income level, occupation and sex, and compare the estimates with the prevalence in the general population.
We systematically searched five databases; Medline, EMBASE, CINHAL Plus, CAB Abstracts, and LILACS for original studies published between 2000 and March 2016 without language restriction. All primary studies that reported tobacco use in any category of HCW were included. Study extraction and quality assessment were conducted independently by three reviewers, using a standardised data extraction and quality appraisal form. We performed random effect meta-analyses to obtain prevalence estimates by World Bank (WB) country income level, sex, and occupation. Data on prevalence of tobacco use in the general population were obtained from the World Health Organisation (WHO) Global Health Observatory website. The review protocol registration number on PROSPERO is CRD42016041231.
229 studies met our inclusion criteria, representing 457,415 HCW and 63 countries: 29 high-income countries (HIC), 21 upper-middle-income countries (UMIC), and 13 lower-middle-and-low-income countries (LMLIC). The overall pooled prevalence of tobacco use in HCW was 21%, 31% in males and 17% in females. Highest estimates were in male doctors in UMIC and LMLIC, 35% and 45%, and female nurses in HIC and UMIC, 21% and 25%. Heterogeneity was high (I2 > 90%). Country level comparison suggest that in HIC male HCW tend to have lower prevalence compared with males in the general population while in females the estimates were similar. Male and female HCW in UMIC and LMLIC tend to have similar or higher prevalence rates relative to their counterparts in the general population.
HCW continue to use tobacco at high rates. Tackling HCW tobacco use requires urgent action as they are at the front line for tackling tobacco use in their patients.
按国家收入水平、职业和性别估算医护人员(HCW)的烟草使用流行率,并将这些估计值与一般人群中的流行率进行比较。
我们系统地检索了五个数据库;Medline、EMBASE、CINHAL Plus、CAB Abstracts 和 LILACS,检索了 2000 年至 2016 年 3 月期间发表的、无语言限制的原始研究。所有报告了任何类别的 HCW 烟草使用情况的原始研究均被纳入。研究提取和质量评估由三名独立审查员使用标准化数据提取和质量评估表进行。我们进行了随机效应荟萃分析,按世界银行(WB)国家收入水平、性别和职业获得流行率估计值。一般人群烟草使用流行率的数据来自世界卫生组织(WHO)全球卫生观察站网站。该综述方案在 PROSPERO 上的注册号为 CRD42016041231。
229 项研究符合纳入标准,代表了 457415 名 HCW 和 63 个国家:29 个高收入国家(HIC)、21 个中上收入国家(UMIC)和 13 个中下收入国家(LMLIC)。HCW 烟草使用的总体汇总流行率为 21%,男性为 31%,女性为 17%。最高的估计值是在 UMIC 和 LMLIC 的男性医生中,分别为 35%和 45%,以及 HIC 和 UMIC 的女性护士中,分别为 21%和 25%。异质性很高(I2 > 90%)。国家层面的比较表明,在 HIC 中,男性 HCW 吸烟的流行率往往低于一般人群中的男性,而女性则相似。UMIC 和 LMLIC 的男性和女性 HCW 的流行率与一般人群中的同类人群相似或更高。
HCW 继续以高比率使用烟草。解决 HCW 的烟草使用问题需要采取紧急行动,因为他们处于应对患者烟草使用问题的第一线。